From Twitter today.
"Our improved #Propofol #TPM® formulation has now successfully passed critical safety studies, supporting its use for continuous 24 hour infusion. This is big win, allowing us to recommence commercial discussions"
I wonder who the discussions are being recommenced with?
- Forums
- ASX - By Stock
- Ann: Improved Propofol TPM Formulation Passes Toxicology Study
From Twitter today."Our improved #Propofol #TPM® formulation has...
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.604K | 534.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 41272233 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39672334 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 41272233 | 0.002 |
28 | 68716741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39672334 | 32 |
0.004 | 30596565 | 18 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 15.59pm 18/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |